Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.

ACTI

Actividentity Corp (MM) (ACTI)

Actividentity Corp (MM)
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:ACTI
DateHeureSourceTitreSymboleSociété
23/05/201920h00GlobeNewswireAnnual General Meeting of Active Biotech ABNASDAQ:ACTIActividentity Corp (MM)
03/05/201913h00GlobeNewswireThe Phase 2 LEGATO-HD study of laquinimod in Huntington's disease will be presented at the scientific conference "American Ac...NASDAQ:ACTIActividentity Corp (MM)
02/05/201913h00GlobeNewswireThe Election Committee of Active Biotech AB proposes Michael Shalmi to be appointed new Chairman of the Board and Uli Hacksel...NASDAQ:ACTIActividentity Corp (MM)
26/04/201911h00GlobeNewswireAnnual Report 2018 Active Biotech AB (publ)NASDAQ:ACTIActividentity Corp (MM)
25/04/201908h30GlobeNewswireActive Biotech AB - Interim report January - March 2019NASDAQ:ACTIActividentity Corp (MM)
24/04/201913h00GlobeNewswireActive Biotech: NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERSNASDAQ:ACTIActividentity Corp (MM)
05/04/201914h15GlobeNewswireActive Biotech completes sale of propertyNASDAQ:ACTIActividentity Corp (MM)
04/04/201918h00GlobeNewswireExtraordinary General Meeting of Active Biotech ABNASDAQ:ACTIActividentity Corp (MM)
13/03/201918h15GlobeNewswireNOTICE OF EXTRAORDINARY SHAREHOLDERS' MEETING OF ACTIVE BIOTECH AB (PUBL)NASDAQ:ACTIActividentity Corp (MM)
13/03/201918h00GlobeNewswireActive Biotech has entered into an agreement regarding sale of the Company's property - extraordinary general meeting on Apri...NASDAQ:ACTIActividentity Corp (MM)
14/02/201908h30GlobeNewswireActive Biotech Year-end report January - December 2018NASDAQ:ACTIActividentity Corp (MM)
11/02/201914h00GlobeNewswireActive Biotech's partner NeoTX enters clinical collaboration with AstraZeneca to evaluate ANYARA in combination with IMFINZI...NASDAQ:ACTIActividentity Corp (MM)
01/02/201916h15GlobeNewswireActive Biotech has received an indicative bid for the property in Lund - the Board is positiveNASDAQ:ACTIActividentity Corp (MM)
10/12/201812h30GlobeNewswireActive Biotech provides updated information about the company's financial positionNASDAQ:ACTIActividentity Corp (MM)
19/11/201808h30GlobeNewswireActive Biotech's election committee appointedNASDAQ:ACTIActividentity Corp (MM)
14/11/201821h30GlobeNewswireActive Biotech AB - Interim report January - September 2018NASDAQ:ACTIActividentity Corp (MM)
08/11/201813h00GlobeNewswireActive Biotech: New data from the Phase 2 LEGATO-HD study will be presented at HSG 2018NASDAQ:ACTIActividentity Corp (MM)
13/09/201811h00GlobeNewswireActive Biotech: Data from the Phase 2 LEGATO-HD study of laquinimod in Huntington's disease will be presented at "European Hu...NASDAQ:ACTIActividentity Corp (MM)
05/09/201808h30GlobeNewswireActive Biotech regains global rights to development and commercialization of laquinimodNASDAQ:ACTIActividentity Corp (MM)
09/08/201808h30GlobeNewswireActive Biotech AB - Interim Report January - June 2018NASDAQ:ACTIActividentity Corp (MM)
31/07/201809h15GlobeNewswireActive Biotech provides update on laquinimod in Huntington's diseaseNASDAQ:ACTIActividentity Corp (MM)
31/05/201808h30GlobeNewswireNumber of shares and votes in Active BiotechNASDAQ:ACTIActividentity Corp (MM)
17/05/201816h00GlobeNewswireActive Biotech AB Interim report January - March 2018NASDAQ:ACTIActividentity Corp (MM)
23/04/201811h30GlobeNewswireAnnual Report 2017 Active Biotech AB (publ)NASDAQ:ACTIActividentity Corp (MM)
18/04/201816h10GlobeNewswireActive Biotech: Notice of Annual General Meeting of ShareholdersNASDAQ:ACTIActividentity Corp (MM)
16/04/201812h40GlobeNewswireActive Biotech's rights issue over subscribedNASDAQ:ACTIActividentity Corp (MM)
12/04/201813h00GlobeNewswireActive Biotech's partner NeoTX presents new data at AACR demonstrating that ANYARA enhances the efficacy of checkpoint blocka...NASDAQ:ACTIActividentity Corp (MM)
27/03/201809h39GlobeNewswireProspectus relating to Active Biotech's rights issue publishedNASDAQ:ACTIActividentity Corp (MM)
15/02/201810h10GlobeNewswireActive Biotech announces rights issue of approximately SEK 48 millionNASDAQ:ACTIActividentity Corp (MM)
15/02/201808h40GlobeNewswireNOTICE OF EXTRAORDINARY SHAREHOLDERS' MEETINGNASDAQ:ACTIActividentity Corp (MM)
 Showing the most relevant articles for your search:NASDAQ:ACTI